Entry date extended

Herbal meds for post-COVID syndrome

+Natural health
In print
Education

Herbal meds for post-COVID syndrome

November 2022

Phil Rasmussen

Tuesday 1 November 2022, 12:40 AM
Ashwaghandha (Withania somnifera)
Ashwaghandha (Withania somnifera) is an adaptogen that improves the body’s ability to cope with stress [Image: Vinayaraj, CC BY-SA 4.0]

Long COVID has the potential to be a long-lasting health burden, but pharmacist and medical herbalist Phil Rasmussen writes there are already many herbs that can help with the wide-ranging symptoms

Post-viral fatigue has been a frequent complaint in pharmacy over recent months, with many patients presenting with ongoing symptoms, especially fatig
References
  1. Michelen M, Manoharan L, Elkheir N, et al. Characterising long COVID: a living systematic review. BMJ Glob Health. 2021;6(9):e005427.
  1. Tirelli U, Taibi R, Chirumbolo S. Post COVID syndrome: a new challenge for medicine. Eur Rev Med Pharmacol Sci. 2021;25(12):4422-4425.
  1. Ceban F, Ling S, Lui LMW, et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav Immun. 2022;101:93-135.
  1. d'Ettorre G, Gentilini Cacciola E, Santinelli L, et al. Covid-19 sequelae in working age patients: A systematic review. J Med Virol. 2022;94(3):858-868
  1. Bucciarelli V, Nasi M, Bianco F, et al. Depression pandemic and cardiovascular risk in the COVID-19 era and long COVID syndrome: Gender makes a difference. Trends Cardiovasc Med. 2022;32(1):12-17.
  1. Maglietta G, Diodati F, Puntoni M, et al. Prognostic Factors for Post-COVID-19 Syndrome: A Systematic Review and Meta-Analysis. J Clin Med. 2022;11(6):1541. 
  1. López-Sampalo A, Bernal-López MR, Gómez-Huelgas R. Persistent COVID-19 syndrome. A narrative review. Rev Clin Esp (Barc). 2022;222(4):241-250.
  1. Stefanou MI, Palaiodimou L, Bakola E, et al. Neurological manifestations of long-COVID syndrome: a narrative review. Ther Adv Chronic Dis. 2022;13:20406223221076890.
  1. Damiano RF, Guedes BF, de Rocca CC, et al. Cognitive decline following acute viral infections: literature review and projections for post-COVID-19. Eur Arch Psychiatry Clin Neurosci. 2022;272(1):139-154.
  1. Alkodaymi MS, Omrani OA, Fawzy NA, et al. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis. Clin Microbiol Infect. 2022;28(5):657-666.
  1. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med. 1994;121(12):953-959.
  1. Tana C, Bentivegna E, Cho SJ, et al. Long COVID headache. J Headache Pain. 2022;23(1):93.
  1. Moldofsky H, Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol. 2011;11:37. doi: 10.1186/1471-2377-11-37
  1. Poenaru S, Abdallah SJ, Corrales-Medina V, Cowan J. COVID-19 and post-infectious myalgic encephalomyelitis/chronic fatigue syndrome: a narrative review. Ther Adv Infect Dis. 2021;8:20499361211009385.
  1. Heyll U, Wachauf P, Senger V, Diewitz M. Definitionen des "Chronic Fatigue Syndrome" (CFS) [Definition of "chronic fatigue syndrome" (CFS)]. Med Klin (Munich). 1997;92(4):221-227.
  1. Mawle AC. Chronic fatigue syndrome. Immunol Invest. 1997;26(1-2):269-273.
  1. Hickie I, Davenport T, Wakefield D, et al. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ. 2006;333(7568):575.
  1. Vanderheiden A, Klein RS. Neuroinflammation and COVID-19. Curr Opin Neurobiol. 2022;76:102608.
  1. Ismail II, Salama S. Association of CNS demyelination and COVID-19 infection: an updated systematic review. J Neurol. 2022;269(2):541-576.
  1. Rasmussen PL, Culinary herbs and spices to know about, in infectious times. www.herbblurb.com 20 March 2020.
  1. Rasmussen PL, Echinacea in the time of a pandemic. www.herbblurb.com 30 October 2020.
  1. Rasmussen PL, Propolis – amazing stuff made by bees from nature. www.herbblurb.com 9 April 2021
  1. Rasmussen PL, Omicron – the latest Covid-19 chapter. www.herbblurb.com 29 Jan 2022.
  1. Jeon, S. R., Kang, J. W., Ang, L., Lee, H. W., Lee, M. S., & Kim, T. H. (2022). Complementary and alternative medicine (CAM) interventions for COVID-19: An overview of systematic reviews. Integrative medicine research, 11(3), 100842.
  1. Ang L, Song E, Hu XY, Lee HW, Chen Y, Lee MS. Herbal Medicine Intervention for the Treatment of COVID-19: A Living Systematic Review and Cumulative Meta-Analysis. Front Pharmacol. 2022;13:906764. Published 2022 Jun 20.
  1. Prajapati SK, Malaiya A, Mishra G, et al. An exhaustive comprehension of the role of herbal medicines in Pre- and Post-COVID manifestations. J Ethnopharmacol. 2022;296:115420.
  1. Barton DL, Liu H, Dakhil SR, et al. Wisconsin Ginseng (Panax quinquefolius) to improve cancer-related fatigue: a randomized, double-blind trial, N07C2. J Natl Cancer Inst. 2013;105(16):1230-1238.
  1. Kim JW, Han SW, Cho JY, et al. Korean red ginseng for cancer-related fatigue in colorectal cancer patients with chemotherapy: A randomised phase III trial. Eur J Cancer. 2020;130:51-62
  1. Devpura G, Tomar BS, Nathiya D, et al. Randomized placebo-controlled pilot clinical trial on the efficacy of ayurvedic treatment regime on COVID-19 positive patients. Phytomedicine. 2021;84:153494.
  1. Patil VS, Hupparage VB, Malgi AP, Deshpande SH, Patil SA, Mallapur SP. Dual inhibition of COVID-19 spike glycoprotein and main protease 3CLpro by Withanone from Withania somnifera. Chin Herb Med. 2021;13(3):359-369.
  1. Qi JH, Dong FX, Wang K, et al. Feasibility analysis and mechanism exploration of Rhei Radix et Rhizome-Schisandrae Sphenantherae Fructus (RS) against COVID-19. J Med Microbiol. 2022;71(5):10.
  1. Kushwaha PP, Singh AK, Prajapati KS, Shuaib M, Gupta S, Kumar S. Phytochemicals present in Indian ginseng possess potential to inhibit SARS-CoV-2 virulence: A molecular docking and MD simulation study. Microb Pathog. 2021;157:104954.
  1. Karosanidze I, Kiladze U, Kirtadze N, et al. Efficacy of Adaptogens in Patients with Long COVID-19: A Randomized, Quadruple-Blind, Placebo-Controlled Trial. Pharmaceuticals (Basel). 2022;15(3):345.
  1. Li XT, Li HC, Li CB, Dou DQ, Gao MB. Protective effects on mitochondria and anti-aging activity of polysaccharides from cultivated fruiting bodies of Cordyceps militaris. Am J Chin Med. 2010;38(6):1093-1106.
  1. Bai X, Tan TY, Li YX, et al. The protective effect of cordyceps sinensis extract on cerebral ischemic injury via modulating the mitochondrial respiratory chain and inhibiting the mitochondrial apoptotic pathway. Biomed Pharmacother. 2020;124:109834.
  1. Song J, Wang Y, Teng M, et al. Studies on the Antifatigue Activities of Cordyceps militaris Fruit Body Extract in Mouse Model. Evid Based Complement Alternat Med. 2015;2015:174616.
  1. Zhao H, Zhang Q, Zhao L, Huang X, Wang J, Kang X. Spore Powder of Ganoderma lucidum Improves Cancer-Related Fatigue in Breast Cancer Patients Undergoing Endocrine Therapy: A Pilot Clinical Trial. Evid Based Complement Alternat Med. 2012;2012:809614.
  1. Jan JT, Cheng TR, Juang YP, et al. Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection. Proc Natl Acad Sci U S A. 2021;118(5):e2021579118.
  1. Yeh H, Vo DNK, Lin ZH, et al. GMI, a protein from Ganoderma microsporum, induces ACE2 degradation to alleviate infection of SARS-CoV-2 Spike-pseudotyped virus. Phytomedicine. 2022;103:154215.
  1. Jędrejko KJ, Lazur J, Muszyńska B. Cordyceps militaris: An Overview of Its Chemical Constituents in Relation to Biological Activity. Foods. 2021;10(11):2634.
  1. Verma AK. Cordycepin: a bioactive metabolite of Cordyceps militaris and polyadenylation inhibitor with therapeutic potential against COVID-19. J Biomol Struct Dyn. 2022;40(8):3745-3752.
  1. Elhusseiny SM, El-Mahdy TS, Awad MF, et al. Proteome Analysis and In Vitro Antiviral, Anticancer and Antioxidant Capacities of the Aqueous Extracts of Lentinula edodes and Pleurotus ostreatus Edible Mushrooms. Molecules. 2021;26(15):4623.
  1. Shahzad F, Anderson D, Najafzadeh M. The Antiviral, Anti-Inflammatory Effects of Natural Medicinal Herbs and Mushrooms and SARS-CoV-2 Infection. Nutrients. 2020;12(9):2573.
  1. Rahman MA, Rahman MS, Bashir NMB, et al. Rationalization of Mushroom-Based Preventive and Therapeutic Approaches to COVID-19: Review. Int J Med Mushrooms. 2021;23(5):1-11
  1. El Dine RS, El Halawany AM, Ma CM, Hattori M. Inhibition of the dimerization and active site of HIV-1 protease by secondary metabolites from the Vietnamese mushroom Ganoderma colossum. J Nat Prod. 2009;72(11):2019-2023.
  1. Zhu Q, Bang TH, Ohnuki K, Sawai T, Sawai K, Shimizu K. Inhibition of neuraminidase by Ganoderma triterpenoids and implications for neuraminidase inhibitor design. Sci Rep. 2015;5:13194. 
  1. Sillapachaiyaporn C, Chuchawankul S. HIV-1 protease and reverse transcriptase inhibition by tiger milk mushroom (Lignosus rhinocerus) sclerotium extracts: In vitro and in silico studies. J Tradit Complement Med. 2019;10(4):396-404. 
  1. Zhang CC, Yin X, Cao CY, Wei J, Zhang Q, Gao JM. Chemical constituents from Hericium erinaceus and their ability to stimulate NGF-mediated neurite outgrowth on PC12 cells. Bioorg Med Chem Lett. 2015;25(22):5078-5082.
  1. Nagano M, Shimizu K, Kondo R, et al. Reduction of depression and anxiety by 4 weeks Hericium erinaceus intake. Biomed Res. 2010;31(4):231-237. 
  1. Chong PS, Fung ML, Wong KH, Lim LW. Therapeutic Potential of Hericium erinaceus for Depressive Disorder. Int J Mol Sci. 2019;21(1):163.
  1. Vigna L, Morelli F, Agnelli GM, et al. Hericium erinaceus Improves Mood and Sleep Disorders in Patients Affected by Overweight or Obesity: Could Circulating Pro-BDNF and BDNF Be Potential Biomarkers?. Evid Based Complement Alternat Med. 2019;2019:7861297.

Class

FRAZ_h_pylori

CLASStime: Helicobacter pylori

Academic pharmacist Nataly Martini provides key information on Helicobacter pylori pathophysiology, diagnosis and evidence-based treatment strategies to enhance patient outcomes

Read more
Wednesday 12 March 2025, 12:55 AM
14 minutes to Read
More Class Articles

Latest news

Te Whatu Ora stops restructuring in some divisions

02/04/2025

Transport boss takes on health’s top job

01/04/2025

Indigestion medicine Zantac returns to pharmacies

01/04/2025

PSNZ invites pharmacists to online meeting about rural pharmacy workforce crisis

31/03/2025

Next-day fix? Te Whatu Ora seeks ‘relentless’ delivery officers replacing deputy CEs

31/03/2025

‘You are not alone’: Pharmacist explains confusing pharmacy payments 

28/03/2025

Hosted Content 2

Hydralyte

Recognising and managing dehydration with Hydralyte

Why recognising the signs of dehydration is important...

Read more
Brought to you by Care Pharmaceuticals
Saturday 1 February 2025, 08:30 AM
2 minutes to Read

Facebook

Pharmacy Today

Latest issue

PT March 25 cover

March 2025

View all issues